Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,710.00
Bid: 1,722.00
Ask: 1,728.00
Change: -60.00 (-3.39%)
Spread: 6.00 (0.348%)
Open: 1,784.00
High: 1,784.00
Low: 1,710.00
Prev. Close: 1,770.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

1 May 2009 07:00

RNS Number : 5549R
Genus PLC
01 May 2009
 



For immediate release 1 May 2009

Genus plc

('Genus' or 'the Company')

Interim Management Statement

Genus, a leading global animal genetics company, today publishes its interim management statement for the four month period ended 30 April 2009.

Trading performance

Genus continued to trade in line with the Board's expectations.

Based on results for the three months to 31 March 2009, trading followed the trend seen at the half year. Profits were well ahead of the prior year, driven by US Dollar and Euro strength against Sterling. In constant currency profits were at similar levels to the prior year. 

In the current economic environment, market conditions for Genus' customers in the USA and Western Europe remained challenging but continued to be less so in Genus' other markets.

Overall Porcine performance continued to be robust. In Bovine, the US dairy sector slowed as milk prices continued to fall This has resulted in increased price competition and trading down by some of Genus' US customers. The impact on profitability has been mitigated by the US productivity improvement programme commenced in January 2009.

Financial Position

Cash flow for the Group in the period was positive despite the payment of the Company's annual dividend in January 2009 and continued planned investment in growthThe Group's net debt at the end of March was £102.7m (31 December 2008: £99.3m). This marginal increase was due to the impact of exchange rate movements on debt levels.

Outlook

Given the challenging global economic environment, Genus expects the markets for its customers to remain challenging in the short term, particularly in the USA. However, the impact on Genus' business is being limited by the Group's geographic and product diversity as well as the robustness of its business model. 

There has been considerable media coverage regarding the recent outbreak of influenza in Mexico and a number of other countries. Dubbed 'swine flu' it is a human strain of an H1N1 flu virus which has been found in humans and cannot be caught by consuming meat products. 

None of Genus' pure line breeding animals is infected with influenza. They are kept under strict bio-security regimes in nucleus farms in the USA and Canada

Speculation regarding the impact of the outbreak has resulted in a reduction in pig prices and precautionary import bans of swine and pork products by some countries. Genus' extensive spread of worldwide multiplication farms makes it better placed than its competitors to maintain supplies in countries where such bans are in place

As a result, whilst keeping the situation under close review, Genus currently expects there to be no material impact on its business from the influenza outbreak and the trading outlook for the financial year remains in line with the Board's expectations.

Genus will announce its preliminary results for the year ending 30 June 2009 on 10 September 2009.

For further information please contact:

Genus plc Tel: 01256 345970

Richard Wood, Chief Executive

John Worby, Finance Director

Buchanan Communications Tel: 0207 466 5000

Charles Ryland, Isabel Podda

About Genus

Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-Genetically Modified Organism (GMO) technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.

Genus' worldwide sales are made in seventy countries under the trademarks "ABS"

(dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain. 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and the Group's global production and distribution network.

Headquartered in BasingstokeEngland, Genus companies operate in 30 countries on six continents, with research laboratories located in MadisonUSA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSDMFASSUSESL
Date   Source Headline
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return
8th Jul 20143:34 pmRNSHolding(s) in Company
7th Jul 20148:42 amRNSHolding(s) in Company
4th Jul 20141:43 pmRNSHolding(s) in Company
2nd Jul 20145:03 pmRNSHolding(s) in Company
1st Jul 201410:00 amRNSTotal Voting Rights
9th Jun 20142:00 pmRNSCompany Secretary Change
27th May 20147:00 amRNSUpdate on Shennong Joint Venture in China
15th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSStrategic Beef Partnership with ABP Food Group
3rd Apr 20144:29 pmRNSDirector/PDMR Shareholding
28th Mar 20142:22 pmRNSDirector/PDMR Shareholding
19th Mar 20144:05 pmRNSBoard Appointments
17th Mar 20144:35 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSInterim Results
10th Feb 20147:00 amRNSCompletion of Acquisition of Genetiporc do Brasil
31st Jan 20142:00 pmRNSBlocklisting Interim Review
31st Jan 20142:00 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSDirector/PDMR Shareholding
12th Dec 20133:00 pmRNSDirector/PDMR Shareholding
29th Nov 20135:01 pmRNSTotal Voting Rights
15th Nov 20133:02 pmRNSResult of AGM
15th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20134:25 pmRNSTotal Voting Rights
29th Oct 20132:30 pmRNSHolding(s) in Company
18th Oct 20137:00 amRNSCompletion of Acquisition of Génétiporc
10th Oct 20134:35 pmRNSAnnual Report & Annual General Meeting
3rd Oct 20132:00 pmRNSAdditional Listing
2nd Oct 20135:00 pmRNSTotal Voting Rights
27th Sep 20136:19 pmRNSDirector/PDMR Shareholding
23rd Sep 20137:00 amRNSGenus to Acquire Génétiporc
3rd Sep 20133:04 pmRNSCorrection of Record Date
3rd Sep 20137:00 amRNSPreliminary Results
31st Jul 20133:00 pmRNSBlocklisting Interim Review
25th Jul 201310:14 amRNSCompany Secretary Appointment
18th Jul 20139:00 amRNSHolding(s) in Company
11th Jun 20135:07 pmRNSHolding(s) in Company
4th Jun 20139:10 amRNSHolding(s) in Company
31st May 20132:00 pmRNSTotal Voting Rights
23rd May 20138:22 amRNSDirector/PDMR Shareholding
21st May 20134:56 pmRNSHolding(s) in Company
30th Apr 20137:00 amRNSInterim Management Statement
8th Apr 20136:09 pmRNSHolding(s) in Company
8th Apr 201310:27 amRNSHolding(s) in Company
28th Mar 20134:13 pmRNSHolding(s) in Company
28th Mar 20133:51 pmRNSTotal Voting Rights
21st Mar 20132:00 pmRNSHolding(s) in Company
11th Mar 20134:07 pmRNSDirector/PDMR Shareholding
4th Mar 20132:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.